USANA Health Sciences Shares Fall 6.4% After Cut to 2024 Sales, EPS Guidance

Dow Jones07-24

By Adam L. Cataldo

Shares of USANA Health Sciences declined following the market's close after the company lowered its guidance for consolidated net sales and earnings per share this year.

The stock slipped 6.4%, to $43, and ended the market session down less than 1%, to close at $45.96. For the year, shares are off by 14%.

USANA now sees sales of $850 million to $880 million, compared with $850 million to $920 million previously. It expects earnings per share of $2.40 to $2.55, down from $2.40 to $3.00.

Salt Lake City-based USANA is a manufacturer nutritional supplements, functional foods and personal-care products.

Write to Adam L. Cataldo at adam.cataldo@wsj.com

(END) Dow Jones Newswires

July 23, 2024 18:52 ET (22:52 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2453094822?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-24 06:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2453094822","market":"nz","top_or_hot":-1,"title":"USANA Health Sciences Shares Fall 6.4% After Cut to 2024 Sales, EPS Guidance","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Adam L. Cataldo \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of USANA Health Sciences declined following the market's close after the company lowered its guidance for consolidated net sales and earnings per share this year. \n</p>\n<p>\n  The stock slipped 6.4%, to $43, and ended the market session down less than 1%, to close at $45.96. For the year, shares are off by 14%. \n</p>\n<p>\n  USANA now sees sales of $850 million to $880 million, compared with $850 million to $920 million previously. It expects earnings per share of $2.40 to $2.55, down from $2.40 to $3.00. \n</p>\n<p>\n  Salt Lake City-based USANA is a manufacturer nutritional supplements, functional foods and personal-care products. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Adam L. Cataldo at adam.cataldo@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2024 18:52 ET (22:52 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>USANA Health Sciences Shares Fall 6.4% After Cut to 2024 Sales, EPS Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUSANA Health Sciences Shares Fall 6.4% After Cut to 2024 Sales, EPS Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-24 06:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Adam L. Cataldo \n\n\n \n\n\n  Shares of USANA Health Sciences declined following the market's close after the company lowered its guidance for consolidated net sales and earnings per share this year. \n\n...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"USNA","symbol_name":"优莎娜","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2453094822","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2453094822","pubTimestamp":1721775120,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of USANA Health Sciences declined following the market's close after the company lowered its guidance for consolidated net sales and earnings per share this year.The stock slipped 6.4%, to $43, and ended the market session down less than 1%, to close at $45.96. For the year, shares are off by 14%.USANA now sees sales of $850 million to $880 million, compared with $850 million to $920 million previously. It expects earnings per share of $2.40 to $2.55, down from $2.40 to $3.00.Salt Lake City-based USANA is a manufacturer nutritional supplements, functional foods and personal-care products.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"USNA":"优莎娜"},"translate_title":"USANA Health Sciences下调2024年销售额和每股收益指引后股价下跌6.4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":0.9},"content_text":"By Adam L. Cataldo \n\n\n \n\n\n  Shares of USANA Health Sciences declined following the market's close after the company lowered its guidance for consolidated net sales and earnings per share this year. \n\n\n  The stock slipped 6.4%, to $43, and ended the market session down less than 1%, to close at $45.96. For the year, shares are off by 14%. \n\n\n  USANA now sees sales of $850 million to $880 million, compared with $850 million to $920 million previously. It expects earnings per share of $2.40 to $2.55, down from $2.40 to $3.00. \n\n\n  Salt Lake City-based USANA is a manufacturer nutritional supplements, functional foods and personal-care products. \n\n\n \n\n\n  Write to Adam L. Cataldo at adam.cataldo@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 23, 2024 18:52 ET (22:52 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2453094822"}